Cargando…
Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR
Alterations in the expression of Fas (CD95/APO-1) and its ligand (FasL) have been demonstrated in various types of cancers as a mechanism for tumour cell to escape from the immune system. In the present study, we evaluated the expression of the Fas and FasL genes in a wide range of primary gynaecolo...
Autores principales: | Das, H, Koizumi, T, Sugimoto, T, Chakraborty, S, Ichimura, T, Hasegawa, K, Nishimura, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374514/ https://www.ncbi.nlm.nih.gov/pubmed/10817504 http://dx.doi.org/10.1054/bjoc.2000.1118 |
Ejemplares similares
-
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2000) -
Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells
por: Ragnarsson, G B, et al.
Publicado: (2000) -
Sex Hormones, Apoptosis and the Fas/Fas Ligand System in Normal Endometrial Tissue Remodeling
por: Mor, Gil, et al.
Publicado: (2001) -
Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms
por: Munakata*, S, et al.
Publicado: (2000) -
Understanding the role of Fas-Fas ligand system in bone
por: Marusic, Ana, et al.
Publicado: (2012)